USPTO serial 79277092
POLYPEPTIDE GROUP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 27, 2021
- Examiner
- MICKLEBURGH, LINDA BOHANNON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with POLYPEPTIDE GROUP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Polypeptide Laboratories Holding (PPL) AB
SE
Other trademarks owned by Polypeptide Laboratories Holding (PPL) AB
Polypeptide Laboratories Holding B.V.
NL
Other trademarks owned by Polypeptide Laboratories Holding B.V.
Polypeptide Laboratories Holding B.V.
NL
Other trademarks owned by Polypeptide Laboratories Holding B.V.
Polypeptide Laboratories Holding B.V.
NL
Other trademarks owned by Polypeptide Laboratories Holding B.V.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations comprised in significant part of peptides for use in industry and science | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations comprised in significant part of peptides for the treatment of various medical conditions, namely viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, hematological, neurodegenerative and nephrological diseases, reproductive health and complement system related diseases and cancer; biological preparations comprised in significant part of polypeptides for medical and veterinary purposes for the treatment of various medical conditions, namely viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, hematological, neurodegenerative and nephrological diseases, reproductive health and complement system related diseases and cancer; medicated shampoos, medicated hair lotions, medicated soaps, and medicated cosmetics | ACTIVE | — |
| 040 | Custom manufacturing services for others in the field of peptide manufacturing | ACTIVE | — |
| 042 | Research and development services in the field of peptide manufacturing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Polypeptide Laboratories Holding (PPL) AB
- Other trademarks owned by Polypeptide Laboratories Holding B.V.
- Other trademarks owned by Polypeptide Laboratories Holding B.V.
- Other trademarks owned by Polypeptide Laboratories Holding B.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named POLYPEPTIDE GROUP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 27, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 18, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 29, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 11, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 11, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 27, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 27, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 6, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 20, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 20, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 6, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 6, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 6, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 6, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 6, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 6, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 5, 2021 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 17, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 15, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 15, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 20, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 2, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 2, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 7, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 31, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 30, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |